Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi

NCT05270421 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Urolithiasis
Nephrolithiasis
Urinary Calculi
Ureterolithiasis

Interventions

DRUG: Furosemide 40 mg
OTHER: Conventional Treatment

Sponsor

Shiraz University of Medical Sciences